{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:20:04Z","timestamp":1783948804259,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-024-01926-9","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T14:55:52Z","timestamp":1733151352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety profile of Onabotulinum toxin-A injection at sphenopalatine ganglion in trigeminal neuralgia: a prospective observational study"],"prefix":"10.1186","volume":"25","author":[{"given":"Marvin","family":"Thepsoparn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakit","family":"Anukoolwittaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patcharapol","family":"Toeypromthong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanon","family":"Thanaboriboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"1926_CR1","doi-asserted-by":"publisher","unstructured":"International Classification of Orofacial Pain, 1st edition, ICOP (2020) (). Cephalalgia. 40(2):129\u2013221. https:\/\/doi.org\/10.1177\/0333102419893823","DOI":"10.1177\/0333102419893823"},{"key":"1926_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/tcrm.S37592","volume":"11","author":"N Montano","year":"2015","unstructured":"Montano N, Conforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F (2015) Advances in diagnosis and treatment of trigeminal neuralgia. Ther Clin Risk Manag 11:289\u2013299. https:\/\/doi.org\/10.2147\/tcrm.S37592","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"1926_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1533-2500.2006.00079.x","volume":"6","author":"T T\u00f6lle","year":"2006","unstructured":"T\u00f6lle T, Dukes E, Sadosky A (2006) Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Pain Pract Sep 6(3):153\u2013160. https:\/\/doi.org\/10.1111\/j.1533-2500.2006.00079.x","journal-title":"Pain Pract Sep"},{"issue":"9","key":"1926_CR4","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s42399-020-00415-9","volume":"09","author":"M Silva","year":"2020","unstructured":"Silva M, Ouanounou A, Trigeminal Neuralgia (2020) Etiology, diagnosis, and treatment. SN Compr Clin Med 09(9):1585\u20131592. https:\/\/doi.org\/10.1007\/s42399-020-00415-9. \/01 2020","journal-title":"SN Compr Clin Med"},{"issue":"6","key":"1926_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3171\/2014.11.Jns141741","volume":"123","author":"AL Ko","year":"2015","unstructured":"Ko AL, Lee A, Raslan AM, Ozpinar A, McCartney S, Burchiel KJ (2015) Trigeminal neuralgia without neurovascular compression presents earlier than trigeminal neuralgia with neurovascular compression. J Neurosurg Dec 123(6):1519\u20131527. https:\/\/doi.org\/10.3171\/2014.11.Jns141741","journal-title":"J Neurosurg Dec"},{"issue":"4","key":"1926_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1533-2500.2009.00298.x","volume":"9","author":"M van Kleef","year":"2009","unstructured":"van Kleef M, van Genderen WE, Narouze S et al (2009) 1. Trigeminal neuralgia. Pain pract. Jul-Aug 9(4):252\u2013259. https:\/\/doi.org\/10.1111\/j.1533-2500.2009.00298.x","journal-title":"Jul-Aug"},{"issue":"3a","key":"1926_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1590\/s0004-282x2008000400012","volume":"66","author":"C Z\u00fa\u00f1iga","year":"2008","unstructured":"Z\u00fa\u00f1iga C, D\u00edaz S, Piedimonte F, Micheli F (2008) Beneficial effects of botulinum toxin type A in trigeminal neuralgia. Arq Neuropsiquiatr Sep 66(3a):500\u2013503. https:\/\/doi.org\/10.1590\/s0004-282x2008000400012","journal-title":"Arq Neuropsiquiatr Sep"},{"issue":"1","key":"1926_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1129-2377-15-65","volume":"27","author":"H Zhang","year":"2014","unstructured":"Zhang H, Lian Y, Ma Y et al (2014) Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial. J Headache Pain Sep 27(1):65. https:\/\/doi.org\/10.1186\/1129-2377-15-65","journal-title":"J Headache Pain Sep"},{"issue":"5","key":"1926_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","volume":"26","author":"KR Aoki","year":"2005","unstructured":"Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology Oct 26(5):785\u2013793. https:\/\/doi.org\/10.1016\/j.neuro.2005.01.017","journal-title":"Neurotoxicology Oct"},{"issue":"2","key":"1926_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/head.12729","volume":"56","author":"MS Robbins","year":"2016","unstructured":"Robbins MS, Robertson CE, Kaplan E et al (2016) The Sphenopalatine Ganglion: anatomy, pathophysiology, and therapeutic targeting in Headache. Headache Feb 56(2):240\u2013258. https:\/\/doi.org\/10.1111\/head.12729","journal-title":"Headache Feb"},{"issue":"7","key":"1926_CR11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1046\/j.1526-4610.2003.03127.x","volume":"43","author":"D Yarnitsky","year":"2003","unstructured":"Yarnitsky D, Goor-Aryeh I, Bajwa ZH et al (2003) 2003 Wolff Award: possible parasympathetic contributions to peripheral and central sensitization during migraine. Headache Jul-Aug 43(7):704\u2013714. https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03127.x","journal-title":"Headache Jul-Aug"},{"issue":"1","key":"1926_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s10194-017-0826-y","volume":"28","author":"KWD Ho","year":"2017","unstructured":"Ho KWD, Przkora R, Kumar S (2017) Sphenopalatine ganglion: block, radiofrequency ablation and neurostimulation - a systematic review. J Headache Pain Dec 28(1):118. https:\/\/doi.org\/10.1186\/s10194-017-0826-y","journal-title":"J Headache Pain Dec"},{"key":"1926_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2147\/jpr.S303305","volume":"14","author":"R Atisook","year":"2021","unstructured":"Atisook R, Euasobhon P, Saengsanon A, Jensen MP (2021) Validity and utility of Four Pain Intensity measures for Use in International Research. J Pain Res 14:1129\u20131139. https:\/\/doi.org\/10.2147\/jpr.S303305","journal-title":"J Pain Res"},{"key":"1926_CR14","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates"},{"issue":"1","key":"1926_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s10194-018-0921-8","volume":"26","author":"L Bendtsen","year":"2018","unstructured":"Bendtsen L, Sacco S, Ashina M et al (2018) Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation. J Headache Pain Sep 26(1):91. https:\/\/doi.org\/10.1186\/s10194-018-0921-8","journal-title":"J Headache Pain Sep"},{"issue":"2","key":"1926_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.11607\/ofph.2510","volume":"34","author":"K Yoshida","year":"2020","unstructured":"Yoshida K (2020) Sphenopalatine Ganglion Block with Botulinum Neurotoxin for treating trigeminal Neuralgia using CAD\/CAM-Derived Injection Guide. J Oral Facial Pain Headache Spring 34(2):135\u2013140. https:\/\/doi.org\/10.11607\/ofph.2510","journal-title":"J Oral Facial Pain Headache Spring"},{"issue":"8","key":"1926_CR17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/head.13608","volume":"59","author":"J Crespi","year":"2019","unstructured":"Crespi J, Bratbak D, Dodick DW, Matharu M, Jamt\u00f8y KA, Tronvik E (2019) Pilot Study of Injection of OnabotulinumtoxinA toward the Sphenopalatine Ganglion for the treatment of classical trigeminal neuralgia. Headache Sep 59(8):1229\u20131239. https:\/\/doi.org\/10.1111\/head.13608","journal-title":"Headache Sep"},{"issue":"1","key":"1926_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41572-024-00523-z","volume":"30","author":"S Ashina","year":"2024","unstructured":"Ashina S, Robertson CE, Srikiatkhachorn A et al (2024) Trigeminal neuralgia. Nat Rev Dis Primers May 30(1):39. https:\/\/doi.org\/10.1038\/s41572-024-00523-z","journal-title":"Nat Rev Dis Primers May"},{"issue":"7","key":"1926_CR19","doi-asserted-by":"publisher","first-page":"333102423118713","DOI":"10.1177\/03331024231187132","volume":"43","author":"KA Jamt\u00f8y","year":"2023","unstructured":"Jamt\u00f8y KA, Thorstensen WM, Stovner LJ et al (2023) Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study. Cephalalgia Jul 43(7):3331024231187132. https:\/\/doi.org\/10.1177\/03331024231187132","journal-title":"Cephalalgia Jul"},{"issue":"10","key":"1926_CR20","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/head.13398","volume":"58","author":"I Aschehoug","year":"2018","unstructured":"Aschehoug I, Bratbak DF, Tronvik EA (2018) Long-term outcome of patients with intractable chronic cluster headache treated with injection of Onabotulinum Toxin A toward the Sphenopalatine Ganglion - An Observational Study. Headache Nov 58(10):1519\u20131529. https:\/\/doi.org\/10.1111\/head.13398","journal-title":"Headache Nov"},{"issue":"4","key":"1926_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/0333102416648328","volume":"37","author":"DF Bratbak","year":"2017","unstructured":"Bratbak DF, Nordg\u00e5rd S, Stovner LJ et al (2017) Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine. Cephalalgia Apr 37(4):356\u2013364. https:\/\/doi.org\/10.1177\/0333102416648328","journal-title":"Cephalalgia Apr"},{"key":"1926_CR22","doi-asserted-by":"publisher","unstructured":"Farham F, Onan D, Martelletti P (2024) Non-migraine Head Pain and Botulinum Toxin. Toxins (Basel) Oct 9(10). https:\/\/doi.org\/10.3390\/toxins16100431","DOI":"10.3390\/toxins16100431"},{"issue":"44","key":"1926_CR23","doi-asserted-by":"publisher","first-page":"15650","DOI":"10.1523\/jneurosci.2618-11.2011","volume":"2","author":"L Restani","year":"2011","unstructured":"Restani L, Antonucci F, Gianfranceschi L, Rossi C, Rossetto O, Caleo M (2011) Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT\/A). J Neurosci Nov 2(44):15650\u201315659. https:\/\/doi.org\/10.1523\/jneurosci.2618-11.2011","journal-title":"J Neurosci Nov"},{"key":"1926_CR24","doi-asserted-by":"publisher","unstructured":"Pearl C, Moxley B, Perry A, Demian N, Dallaire-Giroux C (2022) Management of trigeminal neuralgia with Botulinum Toxin Type A: report of two cases. Dent J (Basel) Nov 3(11). https:\/\/doi.org\/10.3390\/dj10110207","DOI":"10.3390\/dj10110207"},{"issue":"1","key":"1926_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s10194-016-0651-8","volume":"17","author":"ME Morra","year":"2016","unstructured":"Morra ME, Elgebaly A, Elmaraezy A et al (2016) Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain Dec 17(1):63. https:\/\/doi.org\/10.1186\/s10194-016-0651-8","journal-title":"J Headache Pain Dec"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01926-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01926-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01926-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T15:02:56Z","timestamp":1733151776000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01926-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01926-9","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the ethics committee of Chulalongkorn University (IRB no 0270\/66, Certificate of full board approval no. 1132\/2023). The study adhered to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all the patients before participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}